US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 4.375
  • -0.055-1.24%
Trading May 21 10:13 ET
370.31MMarket Cap-8750P/E (TTM)

Anavex Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.65%-5.85M
-8.49%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
6.22%-7.05M
Net income from continuing operations
19.54%-10.55M
33.53%-8.62M
0.99%-47.51M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-26.56%-47.98M
-21.95%-14.29M
-21.48%-12.37M
Other non cash items
----
----
--845K
--500
---500
----
----
----
----
----
Change In working capital
-1,809.64%-3.76M
-153.63%-982K
-53.27%2.51M
-73.62%1.11M
-117.98%-238.25K
94.59%-197K
-47.27%1.83M
859.35%5.36M
371.26%4.2M
262.81%1.33M
-Change in receivables
63.30%-236K
6.87%-840K
-91.86%484K
-116.14%-543.45K
2,931.79%2.57M
41.38%-643K
-123.96%-902K
238.65%5.94M
729.25%3.37M
92.86%-90.84K
-Change in prepaid assets
-80.12%-589K
65.78%-103K
-30,000.00%-299K
62.37%174.41K
5,751.25%154.59K
-276.97%-327K
-1,249.11%-301K
-98.86%1K
210.01%107.41K
-97.95%2.64K
-Change in payables and accrued expense
-479.95%-2.94M
-101.52%-39K
416.27%1.85M
102.54%1.48M
-309.79%-2.97M
131.45%773K
1,049.48%2.56M
-119.15%-584K
-52.13%729.84K
-8.99%1.41M
-Change in other working capital
----
----
--473K
--68
---68
--0
--473K
----
----
----
Cash from discontinued investing activities
Operating cash flow
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.65%-5.85M
-8.49%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
6.22%-7.05M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,354.79%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
-86.11%21.29M
-99.89%2.46K
-92.25%6.91M
Net common stock issuance
----
----
32.83%27.88M
41,554.38%1.19M
29.65%8.53M
----
----
-86.30%20.99M
1,022.83%2.85K
-92.79%6.58M
Proceeds from stock option exercised by employees
-45.30%99K
-77.13%59K
75.84%1.78M
457,122.63%868.34K
-8.69%468.66K
46.65%181K
-30.92%258K
-81.88%1.01M
-100.01%-190
-78.03%513.27K
Net other financing activities
----
----
----
----
----
----
----
87.26%-707K
98.87%-198
95.79%-185.36K
Cash from discontinued financing activities
Financing cash flow
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,354.79%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
-86.11%21.29M
-99.89%2.46K
-92.25%6.91M
Net cash flow
Beginning cash position
0.10%143.77M
1.25%151.02M
-1.94%149.16M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
420.05%152.11M
-2.77%153.2M
102.14%153.34M
Current changes in cash
-144.48%-4.38M
-31.12%-7.26M
163.25%1.87M
6.14%-3.79M
1,042.92%1.35M
348.27%9.85M
-475.83%-5.54M
-102.40%-2.95M
25.87%-4.04M
-100.18%-143.2K
End cash Position
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
-2.77%153.2M
Free cash flow
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.65%-5.85M
-8.49%-7.65M
11.94%-8.49M
-65.50%-5.79M
20.23%-24.24M
47.31%-4.04M
6.22%-7.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.65%-5.85M-8.49%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M6.22%-7.05M
Net income from continuing operations 19.54%-10.55M33.53%-8.62M0.99%-47.51M29.00%-10.15M8.79%-11.28M-25.57%-13.11M-19.20%-12.97M-26.56%-47.98M-21.95%-14.29M-21.48%-12.37M
Other non cash items ----------845K--500---500--------------------
Change In working capital -1,809.64%-3.76M-153.63%-982K-53.27%2.51M-73.62%1.11M-117.98%-238.25K94.59%-197K-47.27%1.83M859.35%5.36M371.26%4.2M262.81%1.33M
-Change in receivables 63.30%-236K6.87%-840K-91.86%484K-116.14%-543.45K2,931.79%2.57M41.38%-643K-123.96%-902K238.65%5.94M729.25%3.37M92.86%-90.84K
-Change in prepaid assets -80.12%-589K65.78%-103K-30,000.00%-299K62.37%174.41K5,751.25%154.59K-276.97%-327K-1,249.11%-301K-98.86%1K210.01%107.41K-97.95%2.64K
-Change in payables and accrued expense -479.95%-2.94M-101.52%-39K416.27%1.85M102.54%1.48M-309.79%-2.97M131.45%773K1,049.48%2.56M-119.15%-584K-52.13%729.84K-8.99%1.41M
-Change in other working capital ----------473K--68---68--0--473K------------
Cash from discontinued investing activities
Operating cash flow -37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.65%-5.85M-8.49%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M6.22%-7.05M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -60.31%7.28M-77.13%59K39.29%29.65M83,354.79%2.06M30.28%9M54.90%18.33M-89.84%258K-86.11%21.29M-99.89%2.46K-92.25%6.91M
Net common stock issuance --------32.83%27.88M41,554.38%1.19M29.65%8.53M---------86.30%20.99M1,022.83%2.85K-92.79%6.58M
Proceeds from stock option exercised by employees -45.30%99K-77.13%59K75.84%1.78M457,122.63%868.34K-8.69%468.66K46.65%181K-30.92%258K-81.88%1.01M-100.01%-190-78.03%513.27K
Net other financing activities ----------------------------87.26%-707K98.87%-19895.79%-185.36K
Cash from discontinued financing activities
Financing cash flow -60.31%7.28M-77.13%59K39.29%29.65M83,354.79%2.06M30.28%9M54.90%18.33M-89.84%258K-86.11%21.29M-99.89%2.46K-92.25%6.91M
Net cash flow
Beginning cash position 0.10%143.77M1.25%151.02M-1.94%149.16M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M420.05%152.11M-2.77%153.2M102.14%153.34M
Current changes in cash -144.48%-4.38M-31.12%-7.26M163.25%1.87M6.14%-3.79M1,042.92%1.35M348.27%9.85M-475.83%-5.54M-102.40%-2.95M25.87%-4.04M-100.18%-143.2K
End cash Position -9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M-2.77%153.2M
Free cash flow -37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.65%-5.85M-8.49%-7.65M11.94%-8.49M-65.50%-5.79M20.23%-24.24M47.31%-4.04M6.22%-7.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg